Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia
Hepatic cholesterol accumulation is an important contributor to hypercholesterolemia, which results in atherosclerosis and cardiovascular disease (CVD). ATP-citrate lyase (ACLY) is a key lipogenic enzyme that converts cytosolic citrate derived from tricarboxylic acid cycle (TCA cycle) to acetyl-CoA...
Saved in:
Main Authors: | Zhifu Xie (Author), Mei Zhang (Author), Qian Song (Author), Long Cheng (Author), Xinwen Zhang (Author), Gaolei Song (Author), Xinyu Sun (Author), Min Gu (Author), Chendong Zhou (Author), Yangming Zhang (Author), Kexin Zhu (Author), Jianpeng Yin (Author), Xiaoyan Chen (Author), Jingya Li (Author), Fajun Nan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quizartinib (AC220): a promising option for acute myeloid leukemia
by: Zhou F, et al.
Published: (2019) -
Application of Layered Strain Technique in NSTE-ACS
by: Nan Zhao, et al.
Published: (2022) -
MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice
by: Yuan Xia, et al.
Published: (2018) -
The Mirror of Literature, Amusement, and Instruction. Volume 12, No. 326, August 9, 1828
by: Various -
MiR-326 inhibits trophoblast growth, migration, and invasion by targeting PAX8 via Hippo pathway
by: Junjie Zang, et al.
Published: (2022)